Europe Epigenetics Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

1. INTRODUCTION

• 1.1 Study Deliverables
• 1.2 Study Assumptions
• 1.3 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Increasing Incidence and Prevalence of Cancer
  • 4.2.2 Increasing Funding for R&D in Healthcare
  • 4.2.3 Rising Epigenetic Applications in Non-Oncology Diseases
• 4.3 Market Restraints
  • 4.3.1 Rising Cost of Instruments
  • 4.3.2 Dearth of Skilled Researchers
• 4.4 Porter's Five Forces Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

• 5.1 By Product
  • 5.1.1 By Kits
  • 5.1.1.1 Bisulfite Conversion Kits
  • 5.1.1.2 Chip-seq Kits
  • 5.1.1.3 RNA Sequencing Market
  • 5.1.1.4 Whole Genome Amplification Market
  • 5.1.1.5 5-HMC and 5-MC Analysis Kits
  • 5.1.1.6 Other Kits
  • 5.1.2 By Reagents
  • 5.1.2.1 Antibodies
  • 5.1.2.2 Buffers
  • 5.1.2.3 Histones
  • 5.1.2.4 Magnetic Beads
  • 5.1.2.5 Primers
  • 5.1.2.6 Other Reagents
  • 5.1.3 By Enzymes
  • 5.1.3.1 DNA - Modifying Enzymes
  • 5.1.3.2 Protein Modifying Enzymes
  • 5.1.3.3 RNA Modifying Enzymes
  • 5.1.4 By Instruments
  • 5.1.4.1 Mass Spectrometer
  • 5.1.4.2 Sonicators
  • 5.1.4.3 Next Generation Sequencers
  • 5.1.4.4 Other Instruments
• 5.2 By Application
  • 5.2.1 Oncology
  • 5.2.2 Non-Oncology
  • 5.2.2.1 Inflammatory Diseases
  • 5.2.2.2 Metabolic Diseases
  • 5.2.2.3 Infectious Diseases
  • 5.2.2.4 Cardiovascular Diseases
  • 5.2.2.5 Other Non-Oncology Applications
  • 5.2.3 Developmental Biology
  • 5.2.4 Other Research Areas
• 5.3 By Technology
  • 5.3.1 DNA Methylation
  • 5.3.2 Histone Methylation
  • 5.3.3 Histone Acetylation
  • 5.3.4 Large noncoding RNA
  • 5.3.5 MicroRNA modification
  • 5.3.6 Chromatin Structures
• 5.4 Geography
  • 5.4.1 Europe
  • 5.4.1.1 Germany
  • 5.4.1.2 UK
  • 5.4.1.3 France
  • 5.4.1.4 Italy
  • 5.4.1.5 Spain
  • 5.4.1.6 Rest of Europe

6. COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 Diagenode Inc.
  • 6.1.2 Epitherapeutics
  • 6.1.3 Illumina, Inc.
  • 6.1.4 Merck & Co.
  • 6.1.5 Qiagen
  • 6.1.6 F. Hoffmann-La Roche AG
  • 6.1.7 Thermo Fisher Scientific
  • 6.1.8 Zymo Research Corporation
• *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS